Opipram (Opipramol Hydrochloride)

Opipramol hydrochloride, the active ingredient in Opipram, is a anxiolytic and antidepressant presented as a tablet for oral use. It is primarily prescribed for anxiety‑related disorders and depressive symptoms in adults.

GNH USA supplies Opipram as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Opipram is used to manage conditions that involve heightened anxiety and depressive symptoms, acting on central nervous system pathways linked to mood regulation. - Generalized Anxiety Disorder: reduces excessive worry and physical tension. - Somatic Symptom Disorder: alleviates persistent bodily complaints without organic cause. - Major Depressive Disorder (adjunctive): supports mood improvement when used with other antidepressants.

Adverse reactions to Opipramol hydrochloride are generally mild to moderate and vary with individual sensitivity.

Common Side Effects: - Drowsiness: feeling ​the ​most ​common ​effect. - Dry mouth: reduced salivation. - Dizziness: light‑headed ​feeling ​during ​postural ​changes. - Constipation: slowed gastrointestinal motility. - Weight gain: modest increase in body weight.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Cardiac arrhythmia: irregular heartbeat. - Suicidal thoughts: emergence ​in ​depressed ​patients. - Neuro‑t‑  t  t  ​          ​      ​